Hookworm Infection Clinical Trial
— SABABUOfficial title:
Evaluating the Impact of an Improved Household Flooring Intervention on Enteric and Parasitic Infections in Rural Settings in the Counties of Bungoma and Kwale, Kenya
The goal of this intervention study is to learn about the impact of household flooring on health in rural Kenya, and test whether providing an improved (cement stabilised, washable) floor improves the health of children and their care providers. The main questions the study aims to answer are: - What is the effect of providing a sealed, washable floor on the prevalence of infections that cause diarrhoea, intestinal worms and sand flea infections? - To what extent does the intervention reduce contamination of floors with pathogens within the home? - What is its effect of the intervention on the wellbeing of caregivers and children? - Over the course of a year, do the new floors remain undamaged, with no cracks? - Do participants living with the new floors, and the masons that helped to install the floors, like them and feel they are practical and affordable? The study will involve a trial, where half of the recruited households will be randomly chosen to receive the new floor in addition to some support on how to care for the floor and keep it clean. The other half of households will not receive anything at first, but at the end of the research project will also receive a new floor. Before the new floors are installed, the investigators will make several assessments in all study households. These will include a survey to measure household characteristics; a stool survey, to measure how many people are infected with diarrhoea-causing microorganisms and parasitic worms; a jigger flea examination among children; wellbeing assessments among children and caregivers; and soil sampling to identify microorganisms on the floor of the household. When households receive the new floor, participants will have to move out of their house for up to 7 days during installation. Participants will also be asked to attend some group meetings to discuss ways of taking care of the floor and keeping it clean. Assessments will be repeated 12 months after the floor has been delivered, and additional interviews will be held with a small number of randomly selected participants. Throughout the 12 months following delivery of the intervention, investigators will make unannounced visits to households to check the condition of the floor. Participants will also be offered treatment for parasitic worm infections after assessments have been completed at the start and end of the project.
Status | Recruiting |
Enrollment | 2200 |
Est. completion date | December 2024 |
Est. primary completion date | August 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Household with a child under 5 years of age that meets structural criteria (unimproved earthen flooring throughout, structurally sound), with members willing to temporarily relocate. Exclusion Criteria: - Households that are intending to move within the next 12 months, or that have improved flooring in any rooms or are not structurally sound. |
Country | Name | City | State |
---|---|---|---|
Kenya | Dzombo ward | Kwale |
Lead Sponsor | Collaborator |
---|---|
London School of Hygiene and Tropical Medicine | International Centre of Insect Physiology and Ecology (ICIPE), Jomo Kenyatta University of Agriculture and Technology, Kenya Medical Research Institute |
Kenya,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Enteric infections | Prevalence of enteric infections (detected through PCR) in children under 5 years old will be assessed using cross-sectional stool surveys including all enrolled children under 5 years before installation of floors and 12 months after receiving the floors. Pathogens to be identified from those observed at baseline using a multipathogen panel on a subset of 100 samples. | 12 months | |
Primary | Tungiasis infections | Prevalence of tungiasis (detected through clinical examination of hands and feet) in children under 15 years old will be assessed using cross-sectional clinical assessment surveys including all enrolled children under 15 years before installation of floors and 12 months after receiving the floors. | 12 months | |
Primary | STH infections | Prevalence of at least one STH infection (hookworm, ascaris and trichuris infections; detected through kato katz) in all household members 12 months and older will be assessed using cross-sectional stool surveys including all enrolled people over 12 months of age before installation of floors and 12 months after receiving the floors. | 12 months | |
Secondary | Gastrointestinal illness | Prevalence of gastrointestinal illness in children under 5 years - assessed in both study arms based on caregiver reported symptoms | 12 months | |
Secondary | Intensity and severity of tungiasis | Intensity of tungiasis and severity of acute and chronic tungiasis-associated pathology in children <15 years - assessed using clinical severity scores (range: 0-110, high scores indicating increased severity/worse outcome) | 12 months | |
Secondary | Quality of Life for children aged 8 to 14 years | Quality of Life assessed in children ages 8 to 14 years in both arms using the standardised EQ5D-Y (EuroQol 5-dimension health-related quality of life tool for children; values are anchored at 1 (full health) and 0 (a state as bad as being dead)) | 12 months | |
Secondary | Quality of Life and subjective wellbeing in primary caregivers | Quality of Life assessed in primary caregivers in both arms using the standardised EQ5D tool (EuroQol 5-dimension health-related quality of life tool for adults; values are anchored at 1 (full health) and 0 (a state as bad as being dead)) | 12 months | |
Secondary | Prevalence of Ascaris lumbricoides infection | Ascaris lumbricoides (roundworm) infection prevalence in all household members >1 year assessed using Kato Katz | 12 months | |
Secondary | Prevalence of hookworm infection | Hookworm infection prevalence in all household members >1 year assessed using Kato Katz | 12 months | |
Secondary | Prevalence of Trichuris trichiura infection | T. trichiura (whipworm) infection prevalence in all household members >1 year assessed using Kato Katz | 12 months | |
Secondary | Environmental contamination - enteric pathogens | Environmental contamination for human-specific and animal faecal markers - assessed from dust/soil samples from household cooking areas and living rooms using PCR. | 12 months | |
Secondary | Environmental contamination - tungiasis | Contamination of floors with eggs, larvae, pupae and adults of T. penetrans - assessed through entomology soil surveys | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03278431 -
Triple Combinations Against Hookworm Infections in Lao
|
Phase 4 | |
Completed |
NCT01717950 -
Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
|
Phase 1 | |
Completed |
NCT02143518 -
Safety and Immunogenicity Study of Na-GST-1 With or Without CpG
|
Phase 1 | |
Completed |
NCT02126462 -
Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults
|
Phase 1 | |
Completed |
NCT01261130 -
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults
|
Phase 1 | |
Completed |
NCT01385189 -
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant
|
Phase 1 | |
Terminated |
NCT00473967 -
Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults
|
Phase 1 | |
Completed |
NCT00603889 -
Development of a Skin Test for the Na-ASP-2 Hookworm Antigen
|
N/A | |
Completed |
NCT02839161 -
Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children
|
Phase 1 | |
Completed |
NCT02476773 -
Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults
|
Phase 1 | |
Recruiting |
NCT01940757 -
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
|
Phase 1 | |
Completed |
NCT00207753 -
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
|
N/A | |
Completed |
NCT03373214 -
Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults
|
Phase 1 | |
Completed |
NCT00939198 -
Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of Brazil
|
N/A | |
Active, not recruiting |
NCT02262403 -
Hookworm Immune Regulation Project
|
N/A | |
Completed |
NCT00120081 -
Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
|
Phase 1 |